Future routine? - Ethics and quality management of genetic investigations;Zukünftige routine? Ethik und qualitäts-management genetischer untersuchungen

Klinikarzt

Volumn 34, Issue 3, 2005, Pages 66-70

  Neumaier, M ^a   Funke, H ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

External round robin test; Genetic diagnosis; Licenses; Patents; Personal rights; Screening program

Indexed keywords

ANALYTIC METHOD; CLINICAL EDUCATION; CLINICAL FEATURE; DIAGNOSTIC TEST; DNA MICROARRAY; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC PROCEDURES; GENETIC RISK; GENETIC SCREENING; HUMAN; HUMAN RIGHTS; LICENCE; MEDICAL ETHICS; MOLECULAR GENETICS; PATENT; PATIENT ATTITUDE; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SKILL; TECHNIQUE;

EID: 16444385809     PISSN: 03412350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-865191     Document Type: Review

References (14)

1. Braun A, Deufel T, Geilenkeuser WJ et al. External quality assessment of molecular biology-based methods used in laboratories of clinical chemistry and human genetics. Clin Chem Lab Med 1998; 36: 231-234
2. Chahine K. Industry opposes genomic legislation. Nat Biotechnol 2002; 20: 419
3. Cho MK, Illangasekare S, Weaver MA et al. Effects of patents and licenses on the provision of clinical genetic testing services. J Mol Diagn 2003; 5: 3-8
4. Funke H, Cullen P, Gessner R et al. Multiparametric gene diagnostics in medicine: Development of consensus standards. J Lab Med 2003; 27: 131-136
5. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004; 431: 931-945
6. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921
7. Lecrubier A. Patents and public health. European institutions are challenging Myriad Genetics's patent monopoly on the brca1 gene. EMBO Rep 2002; 3: 1120-1122
8. Merz JF, Kriss AG, Leonard DG et al. Diagnostic testing fails the test. Nature 2002; 415: 577-579
9. Merz JF, Leonard DG, Kriss AG et al. Industry opposes genomic legislation. Nat Biotechnol 2002; 20: 657; author reply
10. Merz JF, Leonard DG, Miller ER. IRB review and consent in human tissue research. Science 1999; 283: 1647-1648
11. Neumaier M, Braun A, Gessner R et al. Experiences with external quality assessment (EQA) in molecular diagnostics in clinical laboratories in Germany. Working Group of the German Societies for Clinical Chemistry (DGKC) and Laboratory Medicine (DGLM). Clin Chem Lab Med 2000; 38: 161-163
12. Neumaier M, Braun A, Wagener C. Fundamentals of quality assessment of molecular amplification methods in clinical diagnostics. International Federation of Clinical Chemistry Scientific Division Committee on Molecular Biology Techniques. Clin Chem 1998; 44: 12-26
13. Raggi CC, Pinzani P, Paradiso A et al. External quality assurance program for PCR amplification of genomic DNA: an Italian experience. Clin Chem 2003; 49: 782-791
14. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 2001; 291: 1304-1351